Marathi
|
Hindi
Download App
Epaper
Home
City
Latest News
Cricket
LT Premium
National
International
Maharashtra
Opinions
Chhatrapati Sambhajinagar
Nagpur
Entertainment
Photos
Business
Technology
Sports
Lifestyle
Social Viral
Lokmat Games
Health
City
Home
Latest News
Cricket
LT Premium
National
International
Maharashtra
Opinions
Nagpur
Chhatrapati Sambhajinagar
Trending Topics :
Lok Sabha Election 2024
Heatwave In India
Mumbai Water Cut
Maharashtra Lok Sabha Election
IPL 2024
Salman Khan
All
News
Photos
Videos
Gsk
FOLLOW
Gsk, Latest News
Health :
Pfizer and GSK to battle for share of new RSV vaccine market: Report
New Delhi, June 13 US drugmaker Pfizers and British pharma major GSK are likely to face significant competition ... ...
Health :
New malaria therapy for children gets first approval
Sydney, March 15 A new combination drug therapy against a type of malaria in kids aged 2 to ... ...
Health :
New vax shows strong protection against severe Covid in clinical trials
London, Feb 24 European drugmakers Sanofi and GSK have announced positive results from late-stage clinical testing of a ... ...
Health :
GSK's early data shows Covid antibody drug effective against Omicron
London, Dec 3 British drugmaker GlaxoSmithKline has claimed that early laboratory tests show that its antibody drug against ... ...
Health :
Sanofi halts development of mRNA Covid vax
Paris, Sep 29 French drugmaker Sanofi said it has dropped the development of its mRNA Covid-19 vaccine. The ... ...
Health :
GSK-CureVac's 2nd Covid vax shows better immune response
Berlin, Aug 17 The second mRNA Covid-19 Vaccine developed by German biopharmaceutical company CureVac and its British partner ... ...
National :
Sanofi, GSK receive approval for Phase 3 trial of COVID vaccine in India
French pharmaceutical company Sanofi and its British partner GSK (GlaxoSmithKline plc) received approval for their Phase 3 clinical study in India, to assess the safety, efficacy and immunogenicity of their adjuvanted recombinant-protein COVID-19 vac ...
Business :
GSK Pharma posts 6 pc growth in Q4 revenue at Rs 807 crore
GlaxoSmithKline (GSK) Pharmaceuticals clocked 6 per cent growth in revenue for the January to March quarter at Rs 807 crore as compared to the same period of the previous fiscal. ...
Next Page